Sorrento Therapeutics Enters into Research Agreement with University of Texas Medical Branch at Galveston for Testing of COVID-19 Therapeutics Products

Press/Media: Expert Comment

PeriodApr 1 2020

Media coverage

1

Media coverage

  • TitleSorrento Therapeutics Enters into Research Agreement with University of Texas Medical Branch at Galveston for Testing of COVID-19 Therapeutics Products
    Media name/outletMarketLine Financial Deals Tracker (Formerly Datamonitor)
    CountryUnited Kingdom
    Date4/1/20
    PersonsSlobodan Paessler